| Year |
Citation |
Score |
| 2024 |
Muntner P, Hernandez RK, Kent ST, Browning JE, Gilbertson DT, Hurwitz KE, Jick SS, Lai EC, Lash TL, Monda KL, Rothman KJ, Bradbury BD, Brookhart MA. Staging and clean room: Constructs designed to facilitate transparency and reduce bias in comparative analyses of real-world data. Pharmacoepidemiology and Drug Safety. 33: e5770. PMID 38419140 DOI: 10.1002/pds.5770 |
0.588 |
|
| 2023 |
Levintow SN, Nielson CM, Hernandez RK, Breskin A, Pritchard D, Lash TL, Rothman KJ, Gilbertson D, Muntner P, Critchlow C, Brookhart MA, Bradbury BD. Pragmatic considerations for negative control outcome studies to guide non-randomized comparative analyses: A narrative review. Pharmacoepidemiology and Drug Safety. PMID 36965103 DOI: 10.1002/pds.5623 |
0.559 |
|
| 2022 |
Hernandez RK, Nakasian SS, Bollinger L, Bradbury BD, Jick SS, Muntner P, Ng E, Chia V. Changes in Medication Use During Pregnancy for Women with Chronic Conditions: An Analysis of Claims Data. Therapeutic Innovation & Regulatory Science. PMID 36562933 DOI: 10.1007/s43441-022-00489-8 |
0.613 |
|
| 2020 |
Boysen A, Andersen I, Acquavella J, Seesaghur A, Hernandez R, Ehrenstein V. Corrigendum to Use of skeletal-related events preventive agents in patients with solid tumours and bone metastases in central Denmark Annals of Oncology. 31: 443. DOI: 10.1016/J.Annonc.2020.01.003 |
0.365 |
|
| 2019 |
Kim C, Bhatta S, Cyprien L, Fonseca R, Hernandez RK. Incidence of skeletal-related events among multiple myeloma patients in the United States at oncology clinics: Observations from real-world data. Journal of Bone Oncology. 14: 100215. PMID 30666288 DOI: 10.1016/J.Jbo.2018.100215 |
0.393 |
|
| 2019 |
Boysen A, Andersen I, Acquavella J, Seesaghur A, Hernandez R, Ehrenstein V. Use of skeletal-related events preventive agents in patients with solid tumours and bone metastases in central Denmark Annals of Oncology. 30: v731. DOI: 10.1093/Annonc/Mdz265.039 |
0.425 |
|
| 2018 |
McGrath LJ, Hernandez RK, Overman R, Reams D, Liede A, Brookhart MA, O'Donnell E. Initiation and interruption in intravenous bisphosphonate therapy among patients with multiple myeloma in the United States. Cancer Medicine. PMID 30537194 DOI: 10.1002/Cam4.1869 |
0.317 |
|
| 2018 |
Liede A, Hernandez RK, Wade SW, Bo R, Nussbaum NC, Ahern E, Dougall WC, Smyth MJ. An observational study of concomitant immunotherapies and denosumab in patients with advanced melanoma or lung cancer. Oncoimmunology. 7: e1480301. PMID 30524886 DOI: 10.1200/Jco.2018.36.15_Suppl.E21001 |
0.353 |
|
| 2018 |
McGrath LJ, Overman RA, Reams D, Cetin K, Liede A, Narod SA, Brookhart MA, Hernandez RK. Use of bone-modifying agents among breast cancer patients with bone metastasis: evidence from oncology practices in the US. Clinical Epidemiology. 10: 1349-1358. PMID 30288124 DOI: 10.2147/Clep.S175063 |
0.404 |
|
| 2018 |
Liede A, Hernandez RK, Tang ET, Li C, Bennett B, Wong SS, Jandial D. Epidemiology of benign giant cell tumor of bone in the Chinese population. Journal of Bone Oncology. 12: 96-100. PMID 30148063 DOI: 10.1016/J.Jbo.2018.07.003 |
0.343 |
|
| 2018 |
Kim C, Hernandez RK, Cyprien L, Liede A, Cheng PC. Patterns of bisphosphonate treatment among patients with multiple myeloma treated at oncology clinics across the USA: observations from real-world data. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. PMID 29516168 DOI: 10.1007/S00520-018-4133-1 |
0.364 |
|
| 2018 |
Liede A, Wade S, Lethen J, Hernandez RK, Warner D, Abernethy AP, Finelli A. An Observational Study of Concomitant Use of Emerging Therapies and Denosumab or Zoledronic Acid in Prostate Cancer. Clinical Therapeutics. PMID 29395290 DOI: 10.1016/J.Clinthera.2017.12.015 |
0.324 |
|
| 2018 |
Butler AM, Cetin K, Hernandez RK, Diane Reams B, Overman RA, I Kim J, Hirsch BR, Abernethy AP, Liede A, Alan Brookhart M. Treatment dynamics of bone-targeting agents among men with bone metastases from prostate cancer in the United States. Pharmacoepidemiology and Drug Safety. PMID 29316026 DOI: 10.1002/Pds.4360 |
0.36 |
|
| 2018 |
Hernandez RK, Wade SW, Reich A, Pirolli M, Liede A, Lyman GH. Incidence of bone metastases in patients with solid tumors: analysis of oncology electronic medical records in the United States. Bmc Cancer. 18: 44. PMID 29306325 DOI: 10.1186/S12885-017-3922-0 |
0.39 |
|
| 2018 |
Block G, Fu A, Wade S, Jaramillo R, Bhatta S, Raskin L, Hernandez RK. Prevalence and Predictors of Renal Impairment Among Patients with Multiple Myeloma (MM): An Analysis of Oncology Clinic Electronic Health Records Linked to Commercial Claims in the United States Blood. 132: 5657-5657. DOI: 10.1182/Blood-2018-99-115456 |
0.358 |
|
| 2018 |
Ehrenstein V, Ording A, Ulrichsen S, Andersen I, Seesaghur A, Helleberg C, Silkjær T, Hernandez R, Niepel D, Abildgaard N. Population-based use of intravenous bisphosphonates in patients newly diagnosed with symptomatic multiple myeloma in Denmark in 2005-2015: Impact of patient characteristics Annals of Oncology. 29: viii365. DOI: 10.1093/Annonc/Mdy286.017 |
0.338 |
|
| 2017 |
Qian Y, Bhowmik D, Kachru N, Hernandez RK, Cheng P, Liede A. Utilization of agents to prevent skeletal-related events among patients with multiple myeloma: analysis of real-world data. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. PMID 29063388 DOI: 10.1007/S00520-017-3892-4 |
0.361 |
|
| 2017 |
Cronin-Fenton D, Kjærsgaard A, Nørgaard M, Amelio J, Liede A, Hernandez RK, Sørensen HT. Breast cancer recurrence, bone metastases, and visceral metastases in women with stage II and III breast cancer in Denmark. Breast Cancer Research and Treatment. PMID 28948396 DOI: 10.1007/S10549-017-4510-3 |
0.344 |
|
| 2017 |
Jick S, Li L, Gastanaga VM, Liede A, Hernandez RK. Prevalence of hypercalcemia of malignancy among pediatric cancer patients in the UK Clinical Practice Research Datalink database. Clinical Epidemiology. 9: 339-343. PMID 28670142 DOI: 10.2147/Clep.S137616 |
0.532 |
|
| 2017 |
Qian Y, Bhowmik D, Kachru N, Hernandez RK. Longitudinal patterns of bone-targeted agent use among patients with solid tumors and bone metastases in the United States. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. PMID 28120114 DOI: 10.1007/S00520-017-3583-1 |
0.367 |
|
| 2017 |
McGrath LJ, Hernandez RK, Overman R, Reams D, Liede A, Brookhart MA. Patterns and Predictors of Initiation of Intravenous Bisphosphonates Among Patients with Multiple Myeloma in the United States Blood. 130: 534-534. DOI: 10.1182/Blood.V130.Suppl_1.534.534 |
0.416 |
|
| 2017 |
Bhatta S, Cyprien L, Fonseca R, Hernandez RK, Kim C. Multiple Myeloma Patients and Risk of Skeletal Related Events - Real-World Evidence in US Oncology Clinics Blood. 130: 2171-2171. DOI: 10.1182/Blood.V130.Suppl_1.2171.2171 |
0.399 |
|
| 2017 |
Acquavella J, Heide-Jørgensen U, Seesaghur A, Høyer M, Hernandez R, Niepel D, Ehrenstein V. Emerging therapy treatment patterns among Danish metastatic castrate-resistant prostate cancer patients European Urology Supplements. 16: e2700. DOI: 10.1016/S1569-9056(17)31843-2 |
0.306 |
|
| 2016 |
Acquavella J, Ehrenstein V, Schiødt M, Heide-Jørgensen U, Kjellman A, Hansen S, Larsson Wexell C, Herlofson BB, Noerholt SE, Ma H, Öhrling K, Hernandez RK, Sørensen HT. Design and methods for a Scandinavian pharmacovigilance study of osteonecrosis of the jaw and serious infections among cancer patients treated with antiresorptive agents for the prevention of skeletal-related events. Clinical Epidemiology. 8: 267-72. PMID 27499646 DOI: 10.2147/Clep.S107270 |
0.385 |
|
| 2016 |
Liede A, Jerzak KJ, Hernandez RK, Wade SW, Sun P, Narod SA. The incidence of bone metastasis after early-stage breast cancer in Canada. Breast Cancer Research and Treatment. 156: 587-95. PMID 27083181 DOI: 10.1007/S10549-016-3782-3 |
0.421 |
|
| 2016 |
Amelio JM, Rockberg J, Hernandez RK, Sobocki P, Stryker S, Bach BA, Engellau J, Liede A. Population-based study of giant cell tumor of bone in Sweden (1983-2011). Cancer Epidemiology. 42: 82-89. PMID 27060625 DOI: 10.1016/J.Canep.2016.03.014 |
0.377 |
|
| 2016 |
Hernandez RK, Wade SW, Reich A, Pirolli MA, Liede A, Lyman GH. Incidence of bone metastases in U.S. patients with solid tumors. Journal of Clinical Oncology. 34: e13099-e13099. DOI: 10.1200/Jco.2016.34.15_Suppl.E13099 |
0.407 |
|
| 2016 |
Liede A, Butler AM, Cetin K, Hernandez RK, Overman R, Kim J, Reams BD, Hirsch BR, Abernethy AP, Brookhart MA. Initiation and adherence with bone-targeting agents in US men with bone metastases from prostate cancer. Journal of Clinical Oncology. 34: e13083-e13083. DOI: 10.1200/Jco.2016.34.15_Suppl.E13083 |
0.419 |
|
| 2016 |
Kim C, Hernandez RK, Cheng PC, Smith J, Cyprien L, Liede A. Bone Targeting Agent Treatment Patterns Among Patients with Multiple Myeloma Treated at Oncology Clinics Across the United States: Observations from Real-World Data Blood. 128: 2364-2364. DOI: 10.1182/Blood.V128.22.2364.2364 |
0.385 |
|
| 2015 |
Liede A, Hernandez RK, Roth M, Calkins G, Larrabee K, Nicacio L. Validation of International Classification of Diseases coding for bone metastases in electronic health records using technology-enabled abstraction. Clinical Epidemiology. 7: 441-448. PMID 26635485 DOI: 10.2147/Clep.S92209 |
0.345 |
|
| 2015 |
Rockberg J, Bach BA, Amelio J, Hernandez RK, Sobocki P, Engellau J, Bauer HC, Liede A. Incidence Trends in the Diagnosis of Giant Cell Tumor of Bone in Sweden Since 1958. The Journal of Bone and Joint Surgery. American Volume. 97: 1756-66. PMID 26537163 DOI: 10.2106/Jbjs.O.00156 |
0.343 |
|
| 2015 |
Hernandez RK, Adhia A, Wade SW, O'Connor E, Arellano J, Francis K, Alvrtsyan H, Million RP, Liede A. Prevalence of bone metastases and bone-targeting agent use among solid tumor patients in the United States. Clinical Epidemiology. 7: 335-45. PMID 26229504 DOI: 10.2147/Clep.S85496 |
0.386 |
|
| 2015 |
Nguyen-Nielsen M, Liede A, Maegbaek ML, Borre M, Harving N, Hernandez RK, Sørensen HT, Ehrenstein V. Survival and PSA-markers for mortality and metastasis in nonmetastatic prostate cancer treated with androgen deprivation therapy. Cancer Epidemiology. PMID 26100365 DOI: 10.1016/J.Canep.2015.05.008 |
0.302 |
|
| 2015 |
Ehrenstein V, Hernandez RK, Maegbaek ML, Kahlert J, Nguyen-Nielsen M, Nørgaard M, Liede A. Validation of algorithms to detect distant metastases in men with prostate cancer using routine registry data in Denmark. Clinical Epidemiology. 7: 259-65. PMID 25914556 DOI: 10.2147/Clep.S74991 |
0.374 |
|
| 2015 |
Arellano J, Hernandez RK, Wade SW, Chen K, Pirolli M, Quach D, Quigley J, Liede A, Shahinian VB. Prevalence of renal impairment and use of nephrotoxic agents among patients with bone metastases from solid tumors in the United States. Cancer Medicine. 4: 713-20. PMID 25663171 DOI: 10.1002/Cam4.403 |
0.395 |
|
| 2015 |
Sourbeer KN, Howard LE, Moreira DM, Amarasekara HS, Chow LD, Cockrell DC, Hanyok BT, Pratson CL, Kane CJ, Terris MK, Aronson WJ, Cooperberg MR, Amling CL, Hernandez RK, Freedland SJ. Practice patterns and predictors of followup imaging after a negative bone scan in men with castration resistant prostate cancer: results from the SEARCH database. The Journal of Urology. 193: 1232-8. PMID 25463986 DOI: 10.1016/J.Juro.2014.11.014 |
0.302 |
|
| 2015 |
Liede A, Hernandez RK, Roth M, Calkins G, Larrabee K, Nicacio LV. Improving misclassification of ICD-9 coding for bone metastases in electronic medical records (EMR) using technology-enabled abstraction. Journal of Clinical Oncology. 33: e12652-e12652. DOI: 10.1200/Jco.2015.33.15_Suppl.E12652 |
0.397 |
|
| 2015 |
Qian Y, Bhowmik D, Kachru N, Hernandez RK, Cheng P, Liede A. Utilization Patterns of Bone-Targeting Agents Among Patients with Multiple Myeloma: Analysis of Real-World Data Blood. 126: 4501-4501. DOI: 10.1182/Blood.V126.23.4501.4501 |
0.406 |
|
| 2014 |
Liede A, Sandberg J, Amelio J, Hernandez RK, Sobocki P, Bauer HC, Bach B, Engellau J. 1458PTRENDS IN GIANT CELL TUMOUR OF THE BONE AND OSTEOSARCOMA INCIDENCE IN THE SWEDEN (1958-2011). Annals of Oncology : Official Journal of the European Society For Medical Oncology. 25: iv509. PMID 28172217 DOI: 10.1093/Annonc/Mdu354.47 |
0.325 |
|
| 2014 |
Amelio J, Sandberg J, Hernandez R, Sobocki P, Stryker S, Engellau J, Bach B, Liede A. 1460PPOPULATION-BASED STUDY OF GIANT CELL TUMOUR OF THE BONE IN SWEDEN. Annals of Oncology : Official Journal of the European Society For Medical Oncology. 25: iv509-iv510. PMID 28172188 DOI: 10.1093/Annonc/Mdu354.49 |
0.373 |
|
| 2014 |
Liede A, Bach BA, Stryker S, Hernandez RK, Sobocki P, Bennett B, Wong SS. Regional variation and challenges in estimating the incidence of giant cell tumor of bone. The Journal of Bone and Joint Surgery. American Volume. 96: 1999-2007. PMID 25471915 DOI: 10.2106/Jbjs.N.00367 |
0.33 |
|
| 2014 |
Hernandez RK, Quach D, Wade SW, Pirolli M, Quigley J, Narod SA, Liede A. Prevalence of women with early-stage breast cancer receiving active management using electronic health records from oncology clinics in the United States. Breast Cancer Research and Treatment. 146: 637-46. PMID 25053278 DOI: 10.1007/S10549-014-3052-1 |
0.376 |
|
| 2014 |
Banefelt J, Liede A, Mesterton J, Stålhammar J, Hernandez RK, Sobocki P, Persson BE. Survival and clinical metastases among prostate cancer patients treated with androgen deprivation therapy in Sweden. Cancer Epidemiology. 38: 442-7. PMID 24875326 DOI: 10.1016/J.Canep.2014.04.007 |
0.33 |
|
| 2014 |
Hernandez RK, Quigley J, Pirolli M, Quach D, Chen KS, Arellano J, Liede A. Patients with bone metastases from solid tumors initiating treatment with a bone-targeted agent in 2011: a descriptive analysis using oncology clinic data in the US. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. 22: 2697-705. PMID 24789499 DOI: 10.1007/S00520-014-2251-Y |
0.393 |
|
| 2014 |
Hernandez RK, Maegbaek ML, Liede A, Sørensen HT, Ehrenstein V. Bone metastases, skeletal-related events, and survival among children with cancer in Denmark. Journal of Pediatric Hematology/Oncology. 36: 528-33. PMID 24390452 DOI: 10.1097/Mph.0000000000000106 |
0.379 |
|
| 2014 |
Li S, Blaes AH, Liu J, Hu Y, Hernandez RK, Stryker S, Liede A, Collins AJ. Trends in the use of adjuvant anthracycline- and taxane-based chemotherapy regimens in early-stage breast cancer, by surgery type. Journal of Clinical Oncology. 32: e12017-e12017. DOI: 10.1200/Jco.2014.32.15_Suppl.E12017 |
0.303 |
|
| 2014 |
Hernandez RK, Quach D, Wade SW, Pirolli M, Reich A, Quigley J, Liede A. Validation of Bone Metastases Coding in an Oncology Electronic Medical Records Database and a Commercial Claims Database Annals of Epidemiology. 24: 684. DOI: 10.1016/J.Annepidem.2014.06.015 |
0.393 |
|
| 2013 |
Hernandez RK, Banefelt J, Mesterton J, Stålhammar J, Persson B, Ke C, Sobocki P, Liede A. Impact of PSA Doubling Time (DT) Calculation Method on Estimate of Association With Bone Metastases in a Cohort of Prostate Cancer Patients Treated With Androgen Deprivation Therapy (ADT) Pharmacoepidemiology and Drug Safety. 22: 220-220. PMID 24115297 DOI: 10.1002/Pds.3512 |
0.366 |
|
| 2013 |
Ehrenstein V, Hernandez RK, Ulrichsen SP, Rungby J, Lash TL, Riis AH, Li L, Sørensen HT, Jick SS. Rosiglitazone use and post-discontinuation glycaemic control in two European countries, 2000-2010. Bmj Open. 3: e003424. PMID 24068766 DOI: 10.1136/Bmjopen-2013-003424 |
0.512 |
|
| 2013 |
Hagberg KW, Taylor A, Hernandez RK, Jick S. Incidence of bone metastases in breast cancer patients in the United Kingdom: Results of a multi-database linkage study using the general practice research database Cancer Epidemiology. 37: 240-246. PMID 23416031 DOI: 10.1016/J.Canep.2013.01.006 |
0.565 |
|
| 2013 |
Quigley JM, Hernandez RK, Cetin K, Pirolli MA, Quach D, Liede A. Patterns of treatment (tx) with bone-modifying agents (BMA) in patients with bone metastases (mets). Journal of Clinical Oncology. 31: e20690-e20690. DOI: 10.1200/Jco.2013.31.15_Suppl.E20690 |
0.337 |
|
| 2013 |
Hernandez RK, Mesterton J, Banefelt J, Stålhammar J, Sobocki P, Persson B, Liede A. Predictors of clinical metastases and survival among nonmetastatic prostate cancer (PC) patients (pts) treated with androgen-deprivation therapy (ADT) in Sweden. Journal of Clinical Oncology. 31: e16066-e16066. DOI: 10.1200/Jco.2013.31.15_Suppl.E16066 |
0.402 |
|
| 2013 |
Chen KS, Hernandez RK, Quigley JM, Pirolli MA, Quach D, Liede A, Arellano J. Prevalence of renal insufficiency (RI) in cancer (Ca) patients (pts) with bone metastases (BM). Journal of Clinical Oncology. 31: e12508-e12508. DOI: 10.1200/Jco.2013.31.15_Suppl.E12508 |
0.337 |
|
| 2012 |
Hernandez RK, Do TP, Critchlow CW, Dent RE, Jick SS. Patient-related risk factors for fracture-healing complications in the United Kingdom General Practice Research Database. Acta Orthopaedica. 83: 653-60. PMID 23140093 DOI: 10.3109/17453674.2012.747054 |
0.477 |
|
| 2012 |
Pirolli M, Hernandez RK, Cetin K, Quigley J, Grant-Huerta Y, Stryker S, Smith P, Adams J, Liede A. Castration resistance and high-risk disease among nonmetastatic (M0) prostate cancer (PC) patients on androgen deprivation therapy (ADT). Journal of Clinical Oncology. 30: 1581-1581. DOI: 10.1200/Jco.2012.30.15_Suppl.1581 |
0.357 |
|
| 2012 |
Hernandez RK, Ehrenstein V, Mægbæk ML, Liede A, Sørensen HT. Incidence of bone metastases among children with cancer in Denmark. Journal of Clinical Oncology. 30: 1579-1579. DOI: 10.1200/Jco.2012.30.15_Suppl.1579 |
0.366 |
|
| 2011 |
Jick SS, Hernandez RK. Risk of non-fatal venous thromboembolism in women using oral contraceptives containing drospirenone compared with women using oral contraceptives containing levonorgestrel: case-control study using United States claims data. Bmj (Clinical Research Ed.). 342: d2151. PMID 21511805 DOI: 10.1136/Bmj.D2151 |
0.523 |
|
| 2011 |
Parkin L, Sharples K, Hernandez RK, Jick SS. Risk of venous thromboembolism in users of oral contraceptives containing drospirenone or levonorgestrel: nested case-control study based on UK General Practice Research Database. Bmj (Clinical Research Ed.). 342: d2139. PMID 21511804 DOI: 10.1136/Bmj.D2139 |
0.523 |
|
| 2010 |
Jick SS, Hagberg KW, Hernandez RK, Kaye JA. Postmarketing study of ORTHO EVRA and levonorgestrel oral contraceptives containing hormonal contraceptives with 30 mcg of ethinyl estradiol in relation to nonfatal venous thromboembolism. Contraception. 81: 16-21. PMID 20004268 DOI: 10.1016/J.Contraception.2009.07.004 |
0.504 |
|
| 2009 |
Hernandez RK, Sørensen HT, Pedersen L, Jacobsen J, Lash TL. Tamoxifen treatment and risk of deep venous thrombosis and pulmonary embolism: a Danish population-based cohort study. Cancer. 115: 4442-9. PMID 19569248 DOI: 10.1002/Cncr.24508 |
0.366 |
|
| 2008 |
Hernandez RK, Sørensen HT, Jacobsen J, Pedersen L, Lash TL. Tamoxifen treatment in Danish breast cancer patients and 5-year risk of arterial atherosclerotic events: a null association. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 17: 2509-11. PMID 18768523 DOI: 10.1158/1055-9965.Epi-08-0570 |
0.378 |
|
| Show low-probability matches. |